Showing 1 - 20 results of 28 for search 'Brian J. Czerniecki', query time: 0.06s
Refine Results
-
1
CD4+ Th1 to the rescue in HER-2+ breast cancer by Lea Lowenfeld, Shuwen Xu, Brian J. Czerniecki
Published 2019-10-01
Article -
2
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy by Julia Terhune, Erik Berk, Brian J. Czerniecki
Published 2013-11-01
Article -
3
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy by Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, Corey Gallen, Amber Beyer, Colin Snyder, Gary Koski, Mary L. Disis, Brian J. Czerniecki, Brian J. Czerniecki, Brian J. Czerniecki, Krithika Kodumudi, Krithika Kodumudi
Published 2021-05-01
Article -
4
-
5
-
6
Occult Breast Carcinoma Presenting as Scalp Metastasis by Ricardo L.B. Costa, Rubens B. Costa-Filho, Marilin Rosa, Brian J. Czerniecki
Published 2017-11-01
Article -
7
Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib. by Loral E Showalter, Crystal Oechsle, Nirmala Ghimirey, Chase Steele, Brian J Czerniecki, Gary K Koski
Published 2019-01-01
Article -
8
-
9
-
10
-
11
-
12
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the... by Krithika N. Kodumudi, Ganesan Ramamoorthi, Colin Snyder, Amrita Basu, Yongsheng Jia, Yongsheng Jia, Sabrina Awshah, Amber P. Beyer, Doris Wiener, Lian Lam, Hongtao Zhang, Mark I. Greene, Ricardo L. B. Costa, Ricardo L. B. Costa, Brian J. Czerniecki, Brian J. Czerniecki
Published 2019-08-01
Article -
13
-
14
Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17. by Christopher Paustian, Patricia Taylor, Terrence Johnson, Min Xu, Nancy Ramirez, Kenneth S Rosenthal, Suyu Shu, Peter A Cohen, Brian J Czerniecki, Gary K Koski
Published 2013-01-01
Article -
15
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. by Cheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, Rosemarie Mick, Thomas Garrabrant, Brian J Czerniecki, Lana E Kandalaft, Daniel J Powell, George Coukos
Published 2011-01-01
Article -
16
HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction. by Brett L Ecker, Laura Taylor, Paul J Zhang, Emma E Furth, Gregory G Ginsberg, Matthew T McMillan, Jashodeep Datta, Brian J Czerniecki, Robert E Roses
Published 2016-01-01
Article -
17
Long-Term CD4<sup>+</sup> T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study by Corey Gallen, Christopher W. Dukes, Amy Aldrich, Lauren Macaisa, Qianxing Mo, Christopher L. Cubitt, Shari Pilon-Thomas, Anna R. Giuliano, Brian J. Czerniecki, Ricardo L. B. Costa
Published 2022-11-01
Article -
18
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer by Kamran A. Ahmed, G. Daniel Grass, Amber G. Orman, Casey Liveringhouse, Michael E. Montejo, Hatem H. Soliman, Heather S. Han, Brian J. Czerniecki, Javier F. Torres-Roca, Roberto Diaz
Published 2018-01-01
Article -
19
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma by Krithika Kodumudi, Brian J Czerniecki, Doris Wiener, Ganesan Ramamoorthi, Colin Snyder, Payal Grover, Hongtao Zhang, Mark I Greene, Amrita Basu, Corey Gallen, Ricardo L B Costa, Hyo S Han, Gary Koski
Published 2022-06-01
Article -
20
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2p... by Lea Lowenfeld, Salman Zaheer, Crystal Oechsle, Megan Fracol, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Robert E. Roses, Carla S. Fisher, Elizabeth S. McDonald, Paul J. Zhang, Angela DeMichele, Rosemarie Mick, Gary K. Koski, Brian J. Czerniecki
Published 2017-09-01
Article